Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Semi-Rational Screening of Probiotics from the Fecal Flora of Healthy Adults against DSS-Induced Colitis Mice by Enhancing Anti-Inflammatory Activity and Modulating the Gut Microbiota

  • Wang, Weiwei (Department of Gastroenterology, Cangzhou Central Hospital) ;
  • Xing, Wentao (Department of Gastroenterology, Cangzhou Central Hospital) ;
  • Wei, Sichen (Department of Gastroenterology, Cangzhou Central Hospital) ;
  • Gao, Qiaoying (Tianjin Institute of Acute Abdominal Diseases, Nankai Hospital) ;
  • Wei, Xinliang (Department of Gastroenterology, Cangzhou Central Hospital) ;
  • Shi, Liang (Endoscopy Room, Cangzhou Central Hospital) ;
  • Kong, Yu (Department of Gastroenterology, Cangzhou Central Hospital) ;
  • Su, Zhenhua (Department of Gastroenterology, Cangzhou Central Hospital)
  • Received : 2018.07.03
  • Accepted : 2018.08.15
  • Published : 2019.09.28
Download PDF
⟨ Previous Next ⟩

Abstract

Ulcerative colitis (UC), a chronic inflammatory bowel disease, substantially impacts patients' health-related quality of life. In this study, an effective strategy for discovering high-efficiency probiotics has been developed. First, in order to survive in the conditions of the stomach and intestine, high bile salt-resistant and strong acid-resistant strains were screened out from the fecal flora of healthy adults. Next, the probiotic candidates were rescreened by examining the induction ability of IL-10 (anti-inflammatory factor) production in dextran sodium sulfate (DSS)-induced colitis mice, and Lactobacillus sakei 07 (L07) was identified and selected as probiotic P. In the end, fourteen bifidobacterium strains isolated from stools of healthy males were examined for their antimicrobial activity. Bifidobacterium bifidum B10 (73.75% inhibition rate) was selected as probiotic B. Moreover, the colonic IL-6 and $TNF-{\alpha}$ expression of the DSS-induced colitis mice treated with L. sakei 07 (L07) - B. bifidum B10 combination (PB) significantly decreased and the IL-10 expression was up-regulated by PB compared to the DSS group. Furthermore, Bacteroidetes and Actinobacteria decreased and Firmicutes increased in the DSS group mice, significantly. More interestingly, the intestinal flora biodiversity of DSS colitis mice was increased by PB. Of those, the level of B. bifidum increased significantly. The Bacteriodetes/Firmicutes (B/F) ratio increased, and the concentration of homocysteine and LPS in plasma was down-regulated by PB in the DSS-induced colitis mice. Upon administration of PB, the intestinal permeability of the the DSS-induced colitis mice was decreased by approximately 2.01-fold. This method is expected to be used in high-throughput screening of the probiotics against colitis. In addition, the L. sakei 07 - B. bifidum B10 combination holds potential in UC remission by immunomodulatory and gut microbiota modulation.

Keywords

References

  1. Safarpour AR, Hosseini SV, Mehrabani D. 2013. Epidemiology of inflammatory bowel diseases in iran and Asia; a mini review. Iran. J. Med. Sci. 38: 140-149.
  2. Dolan KT, Chang EB. 2016. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol. Nutr. Food Res. 61.
  3. Frank JA, Reich CI, Sharma S, Weisbaum JS, Wilson BA, Olsen GJ. 2008. Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl. Environ. Microbiol. 74: 2461-2470. https://doi.org/10.1128/AEM.02272-07
  4. He Q, Li X, Liu C, Su L, Xia Z, Li X, et al. 2016. Dysbiosis of the fecal microbiota in the TNBS-induced Crohn's disease mouse model. Appl. Microbiol. Biotechnol. 100: 4485-4494. https://doi.org/10.1007/s00253-015-7205-x
  5. Liuyang, Zhao, Xiang, Zhang. 2017. The Composition of colonic commensal bacteria according to anatomical localization in colorectal cancer. Engineering 3: 90-97. https://doi.org/10.1016/J.ENG.2017.01.012
  6. Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148: 1258-1270. https://doi.org/10.1016/j.cell.2012.01.035
  7. Cohen RD, Woseth DM, T histed RA, H anauer SB. 2000. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am. J. Gastroenterol. 95: 1263-1276. https://doi.org/10.1111/j.1572-0241.2000.01940.x
  8. Ferraris L, Aires J, Waligora-Dupriet AJ, Butel MJ. 2010. New selective medium for selection of bifidobacteria from human feces. Anaerobe 16: 469-471. https://doi.org/10.1016/j.anaerobe.2010.03.008
  9. Plazadiaz J, Fernandezcaballero JA, Chueca N, Garcia F, Gomezllorente C, Saezlara MJ, et al. 2015. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains. Nutrients 7: 3999-4015. https://doi.org/10.3390/nu7063999
  10. Kawahara M, Nemoto M, Nakata T, Kondo S, Takahashi H, Kimura B, et al. 2015. Anti-inflammatory properties of fermented soy milk with Lactococcus lactis subsp. lactis SSU2 in murine macrophage RAW264.7 cells and DSS-induced IBD model mice. Int. Immunopharmacol. 26: 295-303. https://doi.org/10.1016/j.intimp.2015.04.004
  11. Jo SG, Noh EJ, Lee JY, Kim G, Choi JH, Lee ME, et al. 2016. Lactobacillus curvatus WiKim38 isolated from kimchi induces IL-10 production in dendritic cells and alleviates DSSinduced colitis in mice. J. Microbiol. 54: 503-509. https://doi.org/10.1007/s12275-016-6160-2
  12. Liu YW, Su YW, Ong WK, Cheng TH, T sai YC. 2011. Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities. Int. Immunopharmacol. 11: 2159-2166. https://doi.org/10.1016/j.intimp.2011.09.013
  13. Scott KP, M artin JC, Duncan SH, F lint HJ. 2014. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. Fems Microbiol. Ecol. 87: 30-40. https://doi.org/10.1111/1574-6941.12186
  14. Grimm V, Gleinser M, Neu C, Zhurina D, Riedel CU. 2014. Expression of fluorescent proteins in bifidobacteria for analysis of host-microbe interactions. Appl. Environ. Microbiol. 80: 2842-2850. https://doi.org/10.1128/AEM.04261-13
  15. Palmer R. 2011. Fecal matters. Nat. Med. 17: 150-152. https://doi.org/10.1038/nm0211-150
  16. Tyagi N, Moshal KS, Tyagi SC, Lominadze D. 2007. ${\gamma}$-Aminbuturic acid a receptor mitigates homocysteine-induced endothelial cell permeability. Endothelium 14: 315-323. https://doi.org/10.1080/10623320701746164
  17. Chen M, Mei Q, Xu J, Lu C, Fang H, Liu X. 2012. Detection of melatonin and homocysteine simultaneously in ulcerative colitis. Clin. Chim. Acta 413: 30-33. https://doi.org/10.1016/j.cca.2011.06.036
  18. Zijlstra WG, Kampen EJV. 1960. Standardization of hemoglobinometry : I. the extinction coefficient of hemiglobincyanide at ${\lambda}$ = 540 m ${\mu}$ : ${\varepsilon}$ 540 HiCN. Clin. Chim. Acta 5: 719-726. https://doi.org/10.1016/0009-8981(60)90014-0
  19. Sang LX, Bing C, Cong D, Nan G, Liu WX, Min J. 2013. Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats. Int. J. Mol. Sci. 15: 15-28. https://doi.org/10.3390/ijms15010015
  20. Ding SZ, H ao D, Qiao M, Liu XC, Jing HU, Yong-Mei HU, et al. 2016. Effect of homocysteine on the intestinal permeability by regulating MEK-ERK-MLCK signal transduction in experimental colitis rats. Chinese Pharmacological Bulletin 34: 498-502.
  21. Tateishi H, Mitsuyama K, Toyonaga A, Tomoyose M, Tanikawa K. 1997. Role of cytokines in experimental colitis: relation to intestinal permeability. Digestion 58: 271-281. https://doi.org/10.1159/000201454
  22. Gough E, Shaikh H, Manges AR. 2011. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53: 994-1002. https://doi.org/10.1093/cid/cir632
  23. Guo B, Harstall C, Louie T, Zanten SVV, Dieleman LA. 2012. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment. Pharmacol. Ther. 35: 865-875. https://doi.org/10.1111/j.1365-2036.2012.05033.x
  24. Khoruts A. 2014. Faecal microbiota transplantation in 2013: developing human gut microbiota as a class of therapeutics. Nat. Rev. Gastroenterol. Hepatol. 11: 79-80. https://doi.org/10.1038/nrgastro.2013.231
  25. Sokol H, Seksik P, Furet JP, Firmesse O, Nionlarmurier I, Beaugerie L, et al. 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15: 1183-1189. https://doi.org/10.1002/ibd.20903
  26. Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. 2009. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One. 4: e6026. https://doi.org/10.1371/journal.pone.0006026
  27. Scarpellini E, Ianiro G, Attili F, Bassanelli C, Santis AD, Gasbarrini A. 2015. The human gut microbiota and virome: potential therapeutic implications. Dig. Liver Dis. 47: 1007-1012. https://doi.org/10.1016/j.dld.2015.07.008
  28. Preising J, Philippe D, Gleinser M, Wei H, Blum S, Eikmanns BJ, et al. 2010. Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis. Appl. Environ. Microbiol. 76: 3048-3051. https://doi.org/10.1128/AEM.03127-09
  29. Toshimitsu T, Ozaki S, Mochizuki J, Furuichi K, Asami Y. 2017. Effects of Lactobacillus plantarum OLL2712 culture conditions on the anti-inflammatory activity for murine immune cells and obese and type 2 diabetic mice. Appl. Environ. Microbiol. 83: AEM.03001-03016.
  30. Prisciandaro L, Geier M, Butler R, Cummins A, Howarth G. 2009. Probiotics and their derivatives as treatments for inflammatory bowel disease. Inflammatory Bowel Diseases 15: 1906-1914. https://doi.org/10.1002/ibd.20938
  31. Bullock NR, Booth JC, Gibson GR. 2004. Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis. Curr. Issues Intest. Microbiol. 5: 59-64.
  32. Ghosh S, Dai C, Brown K, Rajendiran E, Makarenko S, Baker J, et al. 2011. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am. J. Physiol. Gastrointest Liver Physiol. 301: 39-49. https://doi.org/10.1152/ajpgi.00509.2010
  33. Munyaka PM, Rabbi MF, Khafipour E, Ghia JE. 2016. Acute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice. J. Basic Microbiol. 56: 986-998. https://doi.org/10.1002/jobm.201500726
  34. Zhang G, Meredith TC, Kahne D. 2013. On the essentiality of lipopolysaccharide to Gram-negative bacteria. Curr. Opinion Microbiol. 16: 779-785. https://doi.org/10.1016/j.mib.2013.09.007
  35. Flannigan KL, Agbor TA, Blackler RW, Kim JJ, Khan WI, Verdu EF, et al. 2014. Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis. Proc. Natil. Acad. Sci. USA 111: 13559. https://doi.org/10.1073/pnas.1413390111

Cited by

  1. Apple polyphenols extract alleviated dextran sulfate sodium‐induced ulcerative colitis in C57BL/6 male mice by restoring bile acid metabolism disorder and gut microbiota dysbiosis vol.35, pp.3, 2019, https://doi.org/10.1002/ptr.6910
  2. In Vivo Healthy Benefits of Galacto-Oligosaccharides from Lupinus albus (LA-GOS) in Butyrate Production through Intestinal Microbiota vol.11, pp.11, 2021, https://doi.org/10.3390/biom11111658